Cargando…
Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575547/ https://www.ncbi.nlm.nih.gov/pubmed/34776728 http://dx.doi.org/10.1186/s43162-021-00070-z |
| _version_ | 1784595695492136960 |
|---|---|
| author | Bakshi, Satvinder Singh Bakshi, Sumita |
| author_facet | Bakshi, Satvinder Singh Bakshi, Sumita |
| author_sort | Bakshi, Satvinder Singh |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8575547 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85755472021-11-09 Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19 Bakshi, Satvinder Singh Bakshi, Sumita Egypt J Intern Med Letter to the Editor Springer Berlin Heidelberg 2021-11-09 2021 /pmc/articles/PMC8575547/ /pubmed/34776728 http://dx.doi.org/10.1186/s43162-021-00070-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Bakshi, Satvinder Singh Bakshi, Sumita Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19 |
| title | Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19 |
| title_full | Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19 |
| title_fullStr | Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19 |
| title_full_unstemmed | Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19 |
| title_short | Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19 |
| title_sort | letter to the editor—a need to strengthen the adverse drug reaction reporting during covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575547/ https://www.ncbi.nlm.nih.gov/pubmed/34776728 http://dx.doi.org/10.1186/s43162-021-00070-z |
| work_keys_str_mv | AT bakshisatvindersingh lettertotheeditoraneedtostrengthentheadversedrugreactionreportingduringcovid19 AT bakshisumita lettertotheeditoraneedtostrengthentheadversedrugreactionreportingduringcovid19 |